About CMOCRO
CMOCRO is a Healthcare company based in North Miami Beach (United States) founded in 2010 by Tugrul Kararli. It operates as a pharmaceutical research, development, and manufacturing services are provided. The company has 1 employees. Its website cmocro.com draws about 22 thousand monthly visits. Its Indian entity Fortis Clinical Research Limited reported revenue of ₹2.7 Lakh. Its focus areas include Biopharma Outsourcing and Diversified. Its competitors include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus and 4 more; 2 of its 9 listed competitors have raised funding.
Company details
CMOCRO was established in 2010 in North Miami Beach, United States, as a provider of services in the pharmaceutical sector. Research, development, and manufacturing activities are conducted to support pharmaceutical needs. Operations are centered on these core functions, with a focus on factual delivery in the industry. The company is led by founder Tugrul Kararli, and contributions from figures like news author Chris Adam are noted in its profile.
- Headquarters North Miami Beach, United States
- Employees 1
- Founders Tugrul Kararli
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website cmocro.com
- Legal Name Fortis Clinical Research Limited
- Date of Incorporation 29 Mar, 2005
- Jurisdiction Delhi, India
- Annual Revenue₹2.7 Lakh
FY 2017 · -99% YoY
- Net Loss-₹57.7 Lakh
FY 2017 · -2105% margin
- EBITDA-₹57.4 Lakh
FY 2017 · -2094% margin
- Latest Funding Round$210.03K (USD), Grant
Apr 2021
- InvestorsHHS
& 1 more
- Employee Count1
Associated legal entities of CMOCRO
CMOCRO operates through Fortis Clinical Research Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2017) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Fortis Clinical Research Limited CIN U73100DL2005PLC134482 | Strike Off | 29 Mar 2005 | Delhi, Delhi | ₹0.0 Cr | – | 3 | View details |
Funding Insights of CMOCRO
- Total Rounds 7
- Last Round Grant — $210,030
- First Round $320,370
(Jan 2016)
- Investors Count 2
All 7 funding rounds of CMOCRO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | $210,030 | Grant | – | – | |
| Jan 2020 | $1.9M | Grant | – | – | |
| Apr 2019 | $224,658 | Grant | – | – | |
| Jul 2018 | $225,000 | Grant | – | – | |
| Mar 2017 | $215,000 | Grant | – | – | |
| Jun 2016 | $2.45M | Grant | – | – | |
| Jan 2016 | $320,370 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in CMOCRO
CMOCRO has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for CMOCRO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Fortis Clinical Research Limited (CMOCRO)
Fortis Clinical Research Limited is the primary company behind CMOCRO. The board of Fortis Clinical Research Limited currently have 3 directors; the longest-serving is Harpal Singh, appointed in 2005. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Harpal Singh DIN 00078224 | Director | 18 Jul 2005 | 21 yrs 3 mo | Fortis Clinical Research Limited |
| Shivinder Mohan Singh DIN 00042910 | Director | 25 Jul 2005 | 21 yrs 2 mo | Fortis Clinical Research Limited |
| Malvinder Mohan Singh DIN 00042981 | Director | 25 Jul 2005 | 21 yrs 2 mo | Fortis Clinical Research Limited |
People of CMOCRO
2 people are tracked at CMOCRO (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Tugrul Kararli | Founder | Leadership |
Chris Adam | News Author | Leadership |
Complete people profiles for CMOCRO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of CMOCRO
Figures of Fortis Clinical Research Limited, the primary company behind CMOCRO, for FY 2017. Revenue was ₹2.7 Lakh (-99% year on year). Net loss was -₹57.7 Lakh (-2105% margin). EBITDA was -₹57.4 Lakh (-2094% margin).
- ₹2.7 LakhRevenue · FY 2017 · -99% YoY
- -₹57.7 LakhNet loss · -2105% margin
- -₹57.4 LakhEBITDA · -2094% margin
- ₹4.90 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Fortis Clinical Research Limited are on its company page.
Detailed financial statements for CMOCRO
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of CMOCRO
3 dated milestones of CMOCRO across 11 years, from founding to its latest funding, stage changes and deals.
- Founded CMOCRO is founded.
- Funding First funding round of $320K.
- Funding Latest funding round, Grant, of $210K.
Competitors of CMOCRO
CMOCRO has 9 listed competitors in our database, 2 of them funded. They include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas | |
| cms.net.cn | 1992 | Shenzhen, China | – | – | Generic formulations including tablets, capsules, liquids, and injectables are manufactured. |
Detailed competitors of CMOCRO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CMOCRO
The website of CMOCRO (cmocro.com) receives about 21.8K visits a month and ranks #1,242,657 among all websites worldwide, #1,570 in Biotechnology and Pharmaceuticals.
- Monthly visits21.8K
▼ 2.2% vs previous month
- Unique visitors9.5K
per month
- Global rank#1,242,657
among all websites
- Category rank#1,570
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.8
- Average visit24 sec
- DevicesDesktop 32% · Mobile 68%
Websites whose visitors overlap most with CMOCRO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioduro.com | 100% | 6.9K | #3,126,038 | View details | |
sdbn.org | sdbn.org | 97% | – | #2,959,554 | – |
| portalinnovations.com | 91% | – | #2,779,614 | View details | |
| junshipharma.com | 88% | 2.9K | #3,800,614 | View details | |
| xttrium.com | 30% | 1.8K | #10,399,816 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for CMOCRO
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as CMOCRO (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cmocro
Complete news archive for CMOCRO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CMOCRO
CMOCRO was founded in 2010 and raised its 1st funding round 6 years after it was founded.
CMOCRO is headquartered in North Miami Beach, United States. It is registered at North Miami Beach, Florida, United States.
CMOCRO has 1 employees.
The primary company behind CMOCRO, Fortis Clinical Research Limited, reported revenue of ₹2.7 Lakh for FY 2017, down 99% year on year.
CMOCRO was established in 2010 in North Miami Beach, United States, as a provider of services in the pharmaceutical sector. Research, development, and manufacturing activities are conducted to support pharmaceutical needs. Operations are centered on these core functions, with a focus on factual delivery in the industry. The company is led by founder Tugrul Kararli, and contributions from figures like news author Chris Adam are noted in its profile.
CMOCRO's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
CMOCRO has 2 investors. Key investors include HHS, and European Union.
CMOCRO operates through Fortis Clinical Research Limited.
The legal entities of CMOCRO currently have 3 directors, including Shivinder Mohan Singh, Harpal Singh, Malvinder Mohan Singh.